Mesenchymal stem cells moderate immune response of type 1 diabetes.

about

Transplantation of human fetal pancreatic progenitor cells ameliorates renal injury in streptozotocin-induced diabetic nephropathy.

P2860

Q33846336-6CE5CF35-30EF-42A7-9C0E-70B333EC2890

P2860

Mesenchymal stem cells moderate immune response of type 1 diabetes.

Item

http://www.wikidata.org/entity/Q38977465

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Mesenchymal stem cells moderate immune response of type 1 diabetes.

@en

type

Item

label

Mesenchymal stem cells moderate immune response of type 1 diabetes.

@en

prefLabel

Mesenchymal stem cells moderate immune response of type 1 diabetes.

@en

P1476

Mesenchymal stem cells moderate immune response of type 1 diabetes.

@en

P2093

Junbi Xv

http://www.w3.org/2001/XMLSchema#string

Lisha Li

http://www.w3.org/2001/XMLSchema#string

Qianwen Ming

http://www.w3.org/2001/XMLSchema#string

Shuai Wang

http://www.w3.org/2001/XMLSchema#string

Wenjing Zhang

http://www.w3.org/2001/XMLSchema#string

Xiaotong Wang

http://www.w3.org/2001/XMLSchema#string

Yulin Li

http://www.w3.org/2001/XMLSchema#string

Zheng Li

http://www.w3.org/2001/XMLSchema#string

P2860

Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes

Stem cell therapy to cure type 1 diabetes: from hype to hope.

B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes

Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated β-cell death

PI3kα and STAT1 Interplay Regulates Human Mesenchymal Stem Cell Immune Polarization

Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production

Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway.

A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype.

Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression.

NFAT pulls the strings during CD4+ T helper cell effector functions.

P2888

s00441-016-2499-2

P304

239-248

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00441-016-2499-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

368

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1020017850

http://www.w3.org/2001/XMLSchema#string

P698

27726027

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

Mesenchymal stem cells moderate immune response of type 1 diabetes.

about

P2860

P2860

Mesenchymal stem cells moderate immune response of type 1 diabetes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921